[PDF] Top 20 Estados Unidos, Irán y el impacto del dilema de seguridad en Oriente Medio y Próximo
Has 10000 "Estados Unidos, Irán y el impacto del dilema de seguridad en Oriente Medio y Próximo" found on our website. Below are the top 20 most common "Estados Unidos, Irán y el impacto del dilema de seguridad en Oriente Medio y Próximo".
Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
... Consecutive tissue sections (4 µ m thickness) from the TMAs were cut into adhesive-coated slides and deparaffinized with serial xylene, ethanol gradient, and distilled water. Heat-induced antigen retrieval was performed ... See full document
14
Original Article Clinical significance and prognostic value of STAT3 expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy
... and prognostic value of Signal transducer and activator of transcription 3 (STAT3) were investigated in a cohort (n=52) of patients with diffuse large B-cell lymphoma (DLBCL) ... See full document
36
A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution
... Diffuse large B-cell lymphoma (DLBCL) patients with high Ki-67 expression receive limited benefits from R-CHOP (rituximab, cyclophosphamide, ... See full document
77
Original Article Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphoma
... was also used to evaluate the correlation between HIF-1α and other biomarker expres- sion. EFS was defined as the time from diagno- sis to disease progression, start of salvage treatment, additional (unplanned) ... See full document
62
Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
... as rituximab, cyclophosphamide, vincristine, doxo- rubicin, and prednisone; R-CHOP ...Gene expression profiling (GEP), International Prognostic Index (IPI) and ... See full document
18
Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir
... anaplastic large cell lymphoma; ART : antiretroviral therapy; CHOP: cyclophosphamide, doxorubicin, vincristine and prednisone; CMV: cytomegalovirus; CRP: C reac- ... See full document
32
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
... been treated with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) like chemotherapy before rituximab era and central nerve system (CNS) relapse was ... See full document
7
<p>Switching Fractioned R-CHOP Cycles to Standard R-CHOP Cycles Guided by Endoscopic Ultrasonography in Treating Patients with Primary Gastric Diffuse Large B-Cell Lymphoma</p>
... full-dose-intensity R-CHOP with frac- tioned infusion of cyclophosphamide, doxorubicin and vin- cristine on days one and fi ve, respectively (rituximab 375mg/m 2 d0, ... See full document
7
Original Article Outcomes of 48 patients with primary angioimmunoblastic T-cell lymphoma in real-world clinical practice: a single-center experience
... followed by a bad prognosis. The present study shows that the addition of thalidomide may reduce the possibility of chemotherapeutic drug resistance and improve the effects of che- motherapy drugs, while delaying the ... See full document
148
Original Article Prognostic prediction of diffuse large-B-cell lymphoma with International Index (IPI) and enhanced NCCN-IPI
... BCL2 expression, ABC subtype, gains and translocations affect- ing the BCL6 locus ...important prognostic fac- tor for DLBCL patients, and refined categoriza- tion to capture increments in LDH was neces- ... See full document
80
Primary effusion lymphoma associated with Human Herpes Virus 8 and Epstein Barr virus in an HIV infected woman from Kampala, Uganda: a case report
... Since immunohistochemistry is not routinely available in Uganda, it was carried out at the Institute of Haema- tology and Oncology “L and A Seragnoli”, Bologna University School of Medicine, Bologna, Italy. The alka- ... See full document
9
Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
... Moreover, rituximab, a chimeric monoclonal anti-CD20 antibody combined with CHOP chemotherapy (R- CHOP) has improved outcome in patients with diffuse large B-cell ... See full document
30
Liposomal Vincristine as a Bridge Therapy Prior to CAR-T Therapy in Relapsed and Refractory Diffuse Large B-Cell Lymphoma?
... This clinical case report supports an innovative role for therapies such as VSLI in combination with rituximab prior to T cell harvesting and/or enrollment in a CAR-T trial. Clinically, it is a delicate ... See full document
14
Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV associated multicentric Castleman’s Disease: a case report
... The pathogenesis of MCD remains poorly understood, however infection of immunoblasts with HHV-8 appears to trigger an intense immune response and marked pro- duction of host-derived IL-6. HHV-8 also encodes an early ... See full document
33
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies
... the expression of crucial inflammatory genes ...NMC cell lines and xenograft models with JQ1 displaced the BRD4 fusion protein from nuclear chromatin and induced squamous differentiation, thus exhibiting ... See full document
8
<p>PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP</p>
... of R-CHOP has obviously improved the therapeutic effects of GDLBCL patients, though the number of bene fi ts patients is ...limited. Rituximab plus fi rst-line chemotherapy treatment of GDLBCL reduces ... See full document
6
Operative R0 resection of diffuse large B cell lymphoma of the pelvis: a case report
... after R-CHOP therapy ...the cell of origin classification, in which the tumor profiles are compared to profiles of normal B cells ...center B cell-like (GBC) DLBCL express genes ... See full document
23
Lenalidomide in heavily pretreated refractory diffuse large B cell lymphoma: a case report
... with diffuse large B-cell lymphoma who had an early relapse after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine, and ...stem ... See full document
10
Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness
... of rituximab in NHL many questions still await an ...the rituximab maintenance studies have been conducted over the last 7 years, there is no clear guidance yet about long term safety and ...squamous ... See full document
9
Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape
... Moreover, rituximab is not widely available to phy- sicians and patients in several countries, including the US, Mexico, Turkey, Russia, and ...considered rituximab an easily accessible option in ...to ... See full document
122
Related subjects